Deborah Dunsire
CIK 1332764 · President, CEO · last filed 2026-07-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$961.5K
Companies
5
Total Filings
147
Lifetime Open-Market Net
-$1.48M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MCK | Director | — | $877.23 | — | $0 | 4 | 2026-07-23 |
| RARE | Director | 38,566 | $24.93 | $961.5K | $0 | 11 | 2026-05-18 |
| Syros Pharmaceuticals, Inc. (SYRS) Delisted | Director | 12,000 | $0.00 | $5 | $0 | 6 | 2024-06-07 |
| ALLERGAN INC (AGN) Delisted | Director | 35,462 | — | — | $11.8K | 108 | 2015-02-19 |
| MILLENNIUM PHARMACEUTICALS INC (MLNM) Delisted | President, CEO | 68,899 | — | — | -$1.50M | 11 | 2008-05-15 |
Recent Filings · Page 7 of 15
147 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-05-02 | ALLERGAN INC (AGN) Delisted | Grant (A) | +1,551 | $0 | EDGAR |
| 2013-05-01 | ALLERGAN INC (AGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-04-02 | ALLERGAN INC (AGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-02-04 | ALLERGAN INC (AGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-01-03 | ALLERGAN INC (AGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-12-21 | ALLERGAN INC (AGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-12-05 | ALLERGAN INC (AGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-10-31 | ALLERGAN INC (AGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-10-02 | ALLERGAN INC (AGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-09-26 | ALLERGAN INC (AGN) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.